Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5598)
All Articles published online
|
Publishing Process of This Article
|
Dec 21, 2019 (publication date) through Jan 10, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Dasari A, Joish VN, Perez-Olle R, Dharba S, Balaji K, Halperin DM. Direct costs of carcinoid syndrome diarrhea among adults in the United States. World J Gastroenterol 2019; 25(47): 6857-6865 [PMID: 31885426 DOI: 10.3748/wjg.v25.i47.6857] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i47/6857.htm |
| Number | Citing Articles |
| 1 |
Sara Pusceddu, Roberta Elisa Rossi, Martina Torchio, Natalie Prinzi, Monica Niger, Jorgelina Coppa, Luca Giacomelli, Rodolfo Sacco, Antonio Facciorusso, Francesca Corti, Alessandra Raimondi, Michele Prisciandaro, Elena Colombo, Teresa Beninato, Marta Del Vecchio, Massimo Milione, Maria Di Bartolomeo, Filippo de Braud. Differential Diagnosis and Management of Diarrhea in Patients with Neuroendocrine Tumors. Journal of Clinical Medicine 2020; 9(8): 2468 doi: 10.3390/jcm9082468
|
| 2 |
Anna Koumarianou, Kosmas Daskalakis, Marina Tsoli, Gregory Kaltsas, Marianne Pavel. Efficacy, safety and unmet needs of evolving medical treatments for carcinoid syndrome. Journal of Neuroendocrinology 2022; 34(7) doi: 10.1111/jne.13174
|
| 3 |
Marine Perrier, Charbel Mouawad, Delphine Gueguen, Benoit Thomé, Maryse Lapeyre-Mestre, Thomas Walter. Health care resource use and costs among patients with carcinoid syndrome in France: Analysis of the National Health Insurance Database. Clinics and Research in Hepatology and Gastroenterology 2023; 47(7): 102177 doi: 10.1016/j.clinre.2023.102177
|
| 4 |
Yue Cheng, Lowell Anthony, Chris Delcher, Daniela C Moga, Aman Chauhan, Bin Huang, Val Adams. Prescribing Characteristics of Octreotide Immediate-Release and Long-Acting Release in Patients with Neuroendocrine Tumors. The Oncologist 2023; 28(6): 479 doi: 10.1093/oncolo/oyad057
|
| 5 |
Matthew H Kulke, Hagen F Kennecke, Kris Murali, Vijay N Joish. Changes in Carcinoid Syndrome Symptoms Among Patients Receiving Telotristat Ethyl in US Clinical Practice: Findings from the TELEPRO-II Real-World Study. Cancer Management and Research 2021; : 7439 doi: 10.2147/CMAR.S330429
|
| 6 |
I-Wen Pan, Daniel M. Halperin, Bumyang Kim, James C. Yao, Ya-Chen Tina Shih. A Systematic Review of Economic and Quality-of-Life Research in Carcinoid Syndrome. PharmacoEconomics 2021; 39(11): 1271 doi: 10.1007/s40273-021-01071-0
|
| 7 |
Lehar Khanna, Thorvardur R. Halfdanarson, Mohamad B. Sonbol, Rachel Eiring, Teresa Prond, Michael Camilleri. Bile Acid Malabsorption in Patients with Neuroendocrine Tumors. Digestive Diseases and Sciences 2022; 67(6): 2517 doi: 10.1007/s10620-021-07189-7
|